Vector B2b Drug Developing Associacao Para Investigacao Em Biotecnologia

Where the EU money came from

Funding by EU programme. Amounts are Vector B2b Drug Developing Associacao Para Investigacao Em Biotecnologia's own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Each links to the official record.

• LiverTargetPartner

  Next generation advanced RNA inhibition therapy to treat cardiometabolic disease

  Horizon Europe · 2022–2027 · Project on CORDIS ↗

  €860ktheir share
• CoroPreventionPartner

  Personalized Prevention for Coronary Heart Disease

  Horizon 2020 · 2020–2026 · Project on CORDIS ↗

  €306ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Tampereen Korkeakoulusaatio SrFinland · 2 shared projects
• Idryma Iatroviologikon Ereunon Akademias AthinonGreece · 2 shared projects
• Institut National de la Sante et de la Recherche MedicaleFrance · 1 shared project
• Universitair Medisch Centrum UtrechtNetherlands · 1 shared project
• The University of SheffieldUnited Kingdom · 1 shared project
• Charite - Universitaetsmedizin BerlinGermany · 1 shared project
• Ruprecht-Karls-Universitaet HeidelbergGermany · 1 shared project
• Universita Degli Studi di MilanoItaly · 1 shared project
• Oulun YliopistoFinland · 1 shared project
• Syddansk UniversitetDenmark · 1 shared project
• Uniwersytet JagiellonskiPoland · 1 shared project
• Centro Nacional de Investigaciones Cardiovasculares Carlos Iii (F.s.p.)Spain · 1 shared project
• Universiteit HasseltBelgium · 1 shared project
• Hus-YhtymaFinland · 1 shared project
• Astrazeneca ABSweden · 1 shared project
• Societe Europeenne de CardiologieFrance · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• RNA
• mortality
• obesity
• toxicology